Global, regional, and national burdens of Alzheimer’s disease and other forms of dementia in the elderly population from 1999 to 2019: A trend analysis based on the Global Burden of Disease Study 2019

Abstract

Dementia represents a significant health issue, afflicting both patients and their families. To assess the global trends in the incidence, prevalence, mortality, and disability-adjusted life years (DALYs) of Alzheimer’s disease (AD) and other dementias in the elderly population, the Global Burden of Disease Study (1999–2019) was used. The average annual percentage change (AAPC) was estimated using linear regression. Stratified analysis of the global trends by age, sex, region, national level, and social development index (SDI) were also performed. The global incidence of AD and other dementias increased from 507.96 per 100,000 in 1990 to 569.39 per 100,000 in 2019, showing a significant increase in this period. In males, the incidence increased from 387.56 per 100,000 population in 1990 to 462.40 per 100,000 in 2019 (AAPC = 0.61), whereas females experienced a slower rise (AAPC = 0.31) and had a higher incidence in 2019 (662.93 per 100,000 population). The most significant increase was observed in individuals aged 60–64 and those in the middle-SDI quintile. Regionally, the high-income Asia Pacific had the highest incidence (890.01 per 100,000 population) and DALYs (3043.86 per 100,000) in AD and other dementias in 2019. As for national trends, Japan had the most pronounced increase in the incidence and DALYs of AD and other dementias during the 1990–2019 period. These findings highlight the growing burden of dementias on life expectancy at a population level, which is significant for healthcare professionals and decision-makers to conduct the ongoing debate on the policy of AD and other dementias.

Keywords

Alzheimer’s disease / dementias / disability-adjusted life years / elderly population / global burden of disease

References

[1] Oh ES, Rabins PV. Dementia. Ann Intern Med. 2019;171(5):ITC33-ITC48.

[2] Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur J Neurol. 2018;25(1):59-70.

[3] Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009;11(2):111-128.

[4] Tu JY, Jin G, Chen JH, Chen YC. Caregiver burden and dementia: a systematic review of self-report instruments. J Alzheimer’s Dis. 2022;86(4):1527-1543.

[5] Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res. 2012;43(8):600-608.

[6] Centers for Disease Control and Prevention. Public health and aging: trends in aging: United States and worldwide. JAMA. 2003;289(11):1371-1373.

[7] Grande G, Qiu C, Fratiglioni L. Prevention of dementia in an ageing world: evidence and biological rationale. Ageing Res Rev. 2020;64:101045.

[8] Vos T, Lim SS, Abbafati C, et al. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019:a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-1222.

[9] Nichols E, Szoeke C, Vollset SE, et al. GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2016:a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88-106.

[10] Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010:a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-2223.

[11] Feigin VL, Stark BA, Johnson CO, et al. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795-820.

[12] Browne AJ, Chipeta MG, Fell FJ, et al. GRAM Typhoid Collaborators. Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019:a modelling study. Lancet Global Health. 2024;12(3):e406-e418.

[13] Greenland S, Senn SJ, Rothman KJ, et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31(4):337-350.

[14] Nichols E, Steinmetz JD, Vollset SE, et al. GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050:an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105-e125.

[15] Kanasi E, Ayilavarapu S, Jones J. The aging population: demographics and the biology of aging. Periodontol 2000. 2016;72(1):13-18.

[16] 2022 Alzheimer’s disease facts and figures. Alzheimer’s Dementia. 2022;18(4):700-789.

[17] Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35(3):347-369.

[18] Eid RS, Gobinath AR, Galea LAM. Sex differences in depression: insights from clinical and preclinical studies. Prog Neurobiol. 2019;176:86-102.

[19] Ardekani BA, Convit A, Bachman AH. Analysis of the MIRIAD data shows sex differences in hippocampal atrophy progression. J Alzheimer’s Dis. 2016;50(3):847-857.

[20] Tower J. Sex-specific gene expression and life span regulation. Trends Endocrinol Metabolism. 2017;28(10):735-747.

[21] Wu YT, Beiser AS, Breteler MMB, et al. The changing prevalence and incidence of dementia over time: current evidence. Nat Rev Neurol. 2017;13(6):327-339.

[22] Power R, Prado-Cabrero A, Mulcahy R, Howard A, Nolan JM. The role of nutrition for the aging population: implications for cognition and Alzheimer’s disease. Annual Rev Food Sci Technol. 2019;10:619-639.

[23] Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017;389(10076):1323-1335.

[24] Gao Y, Liu X. Secular trends in the incidence of and mortality due to Alzheimer’s disease and other forms of dementia in China from 1990 to 2019:an age-period-cohort study and joinpoint analysis. Front Aging Neurosci. 2021;13:709156.

RIGHTS & PERMISSIONS

2024 The Authors. Ibrain published by Affiliated Hospital of Zunyi Medical University (AHZMU) and Wiley-VCH GmbH.